1-7 of 7
James Foran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular and clinical characterization of ETNK1 -mutated myeloid neoplasms: the Mayo Clinic experience

Steven Tessier, Rong He, Patricia Greipp, David Viswanatha, Kurt Bessonen, Terra Lasho, James Foran, Cecilia Arana-Yi, Naseema Gangat, Ayalew Tefferi, Mithun Shah, Hassan Alkhateeb, Shujun Liu, Animesh Pardanani, Mrinal Patnaik, Aref Al-Kali
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4807–4811.
https://doi.org/10.1182/bloodadvances.2024013255
Published: 2024
Includes: Supplemental data
Journal Articles

The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance

Marissa Li, Anmol Baranwal, Mark Gurney, Syed N. Shah, Aref Al-Kali, Hassan Alkhateeb, James Foran, Cecilia Arana Yi, Laura Ongie, Dong Chen, Abhishek Mangaonkar, Kristen McCullough, Ayalew Tefferi, Terra Lasho, Christy Finke, Mrinal M. Patnaik, Mithun Vinod Shah
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3130–3139.
https://doi.org/10.1182/bloodadvances.2023012357
Published: 2024
Includes: Supplemental data
Journal Articles

Genetic features and outcomes of allogeneic transplantation in patients with WT1 -mutated myeloid neoplasms

Clinical Trials & Observations
Anmol Baranwal, Rami Basmaci, Rong He, David Viswanatha, Patricia Greipp, Hemant S. Murthy, James Foran, Jeanne Palmer, William J. Hogan, Mark R. Litzow, Mehrdad Hefazi, Abhishek Mangaonkar, Mithun Vinod Shah, Aref Al-Kali, Hassan B. Alkhateeb
Journal: Blood Advances
Blood Adv (2024) 8 (3): 562–570.
https://doi.org/10.1182/bloodadvances.2023010960
Published: 2024
Includes: Supplemental data
Journal Articles

Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia

Clinical Trials & Observations
Farhad Ravandi, Asad Bashey, James Foran, Wendy Stock, Raya Mawad, Nicholas Short, Musa Yilmaz, Hagop Kantarjian, Olatoyosi Odenike, Anand Patel, Raman Garcha, William Barrett Ainsworth, Raphael Clynes, Jitendra Kanodia, Ying Ding, Huajiang Li, Steve Kye, Alice Mims
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6492–6505.
https://doi.org/10.1182/bloodadvances.2023010956
Published: 2023
Includes: Supplemental data
Journal Articles

Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories

Clinical Trials & Observations
Uma Borate, Fei Yang, Richard Press, Amy S. Ruppert, Dan Jones, Sean Caruthers, Weiqiang Zhao, Jo-Anne Vergilio, Dean C. Pavlick, Luke Juckett, Brianna Norris, Taylor Bucy, Amy Burd, Eytan M. Stein, Prapti Patel, Maria R. Baer, Wendy Stock, Gary Schiller, William Blum, Tibor Kovacsovics, Mark Litzow, James Foran, Nyla A. Heerema, Leonard Rosenberg, Sonja Marcus, Ashley Yocum, Mona Stefanos, Brian Druker, John C. Byrd, Ross L. Levine, Alice Mims
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6048–6054.
https://doi.org/10.1182/bloodadvances.2022009008
Published: 2023
Includes: Supplemental data
Journal Articles

Clinical and prognostic impact of STAG2 mutations in myeloid neoplasms: the Mayo Clinic experience

Bahga Katamesh, Ahmad Nanaa, Rong He, David Viswanatha, Phuong Nguyen, Patricia Greipp, Kurt Bessonen, Naseema Gangat, Kebede Begna, Abhishek Mangaonkar, Mrinal Patnaik, William J. Hogan, Ayalew Tefferi, Mark Litzow, Mithun Vinod Shah, Cecilia Arana Yi, James Foran, Talha Badar, Hassan B. Alkhateeb, Aref Al-Kali
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1351–1355.
https://doi.org/10.1182/bloodadvances.2022007937
Published: 2023
Includes: Supplemental data
Journal Articles

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Clinical Trials & Observations
Zheng Zhou, Rajneesh Nath, Jan Cerny, Hai-Lin Wang, Mei-Jie Zhang, Hisham Abdel-Azim, Vaibhav Agrawal, Gulrayz Ahmed, A. Samer Al-Homsi, Mahmoud Aljurf, Hassan B. Alkhateeb, Amer Assal, Ulrike Bacher, Ashish Bajel, Qaiser Bashir, Minocher Battiwalla, Vijaya Raj Bhatt, Michael Byrne, Jean-Yves Cahn, Mitchell Cairo, Hannah Choe, Edward Copelan, Corey Cutler, Moussab B. Damlaj, Zachariah DeFilipp, Marcos De Lima, Miguel Angel Diaz, Nosha Farhadfar, James Foran, César O. Freytes, Aaron T. Gerds, Usama Gergis, Michael R. Grunwald, Zartash Gul, Mehdi Hamadani, Shahrukh Hashmi, Mark Hertzberg, Gerhard C. Hildebrandt, Nasheed Hossain, Yoshihiro Inamoto, Luis Isola, Tania Jain, Rammurti T. Kamble, Muhammad Waqas Khan, Mohamed A. Kharfan-Dabaja, Partow Kebriaei, Natasha Kekre, Nandita Khera, Hillard M. Lazarus, Jane L. Liesveld, Mark Litzow, Hongtao Liu, David I. Marks, Rodrigo Martino, Vikram Mathews, Asmita Mishra, Hemant S. Murthy, Arnon Nagler, Ryotaro Nakamura, Sunita Nathan, Taiga Nishihori, Rebecca Olin, Richard F. Olsson, Neil Palmisiano, Sagar S. Patel, Mrinal M. Patnaik, Attaphol Pawarode, Miguel-Angel Perales, Ioannis Politikos, Uday Popat, David Rizzieri, Brenda M. Sandmaier, Bipin N. Savani, Sachiko Seo, Nirav N. Shah, Geoffrey L. Uy, David Valcárcel, Leo F. Verdonck, Edmund K. Waller, Youjin Wang, Daniel Weisdorf, Baldeep Wirk, Eric Wong, Jean A. Yared, Wael Saber
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3180–3190.
https://doi.org/10.1182/bloodadvances.2019001266
Published: 2020
Includes: Supplemental data